1. Home
  2. Publications

Publications

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship.

Abstract

OBJECTIVES: We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial.

Bhatt NB Baudin E Meggi B da Silva C Barrail-Tran A Furlan V Grinsztejn B Bonnet M Taburet AM
The Journal of antimicrobial chemotherapy 2015 Jan ; 70(1); 225-32. doi: 10.1093/jac/dku348. Epub 2014 09 18
TB/HIV coinfection drug–drug interactions efavirenz nevirapine

Prevalence and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda.

Abstract

AIM: To determine the prevalence and genotypic characterisation of extended spectrum beta-lactamases produced by gram negative bacilli isolated at Mbarara Regional Referral Hospital (MRRH).

Moses A Bwanga F Boum Y Bazira J
British microbiology research journal 2014 Dec ; 4(12); 1541-1550. doi: 10.9734/BMRJ/2014/9792. Epub 2018 11 13
Antibiotics ESBL Uganda resistance patterns sensitivity patterns

Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.

Abstract

BACKGROUND: In 2009, a large meningitis A epidemic affected a broad region of northern Nigeria and southern Niger, resulting in more than 75 000 cases and 4000 deaths.

Ferrari MJ Fermon F Nackers F Llosa A Magone C Grais RF
International health 2014 Dec ; 6(4); 282-90. doi: 10.1093/inthealth/ihu062. Epub 2014 09 05
Meningitis surveillance Neisseria meningitidis serogroup A Nigeria Polysaccharide vaccine Vaccination outbreak response

Post-licensure deployment of oral cholera vaccines: a systematic review.

Abstract

OBJECTIVE: To describe and analyse the characteristics of oral cholera vaccination campaigns; including location, target population, logistics, vaccine coverage and delivery costs.

Martin S Lopez AL Bellos A Deen J Ali M Alberti K Anh DD Costa A Grais RF Legros D Luquero FJ Ghai MB Perea W Sack DA
Bulletin of the World Health Organization 2014 Dec 01; 92(12); 881-93. doi: 10.2471/BLT.14.139949. Epub 2014 09 29

A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain.

Abstract

BACKGROUND: In resource-poor settings, cold chain requirements present barriers for vaccine delivery.

Juan-Giner A Domicent C Langendorf C Roper MH Baoundoh P Fermon F Gakima P Zipursky S Tamadji M Grais RF
Vaccine 2014 Oct 29; 32(47); 6220-6. doi: 10.1016/j.vaccine.2014.09.027. Epub 2014 09 26
Cold chain Controlled temperature chain Immunogenicity Maternal and neonatal tetanus elimination NCT01559597 Tetanus toxoid

Physiotherapy for poliomyelitis: a descriptive study in the Republic of Congo.

Abstract

BACKGROUND: A large poliomyelitis outbreak occurred in 2010 in the Republic of Congo. This paper describes the demographic and clinical characteristics of poliomyelitis cases and their outcomes following physiotherapy.

Mancini S Coldiron ME Nicholas S Llosa AE Mouniaman-Nara I Ngala J Grais RF Porten K
BMC research notes 2014 Oct 23; 7 755. doi: 10.1186/1756-0500-7-755. Epub 2014 10 23